Target Validation Before First-in-Human: What Preclinical Packages Systematically Omit. Translational Medicine & Therapeutics Journal, [S. l.], v. 1, n. 1, p. 1–9, 2022. DOI: 10.5281/zenodo.22648817. Disponível em: https://inkwise.org/index.php/TMTJ/article/view/64. Acesso em: 5 nov. 2026.